Related Experiment Video
Updated: Sep 20, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Increased Thrombogenicity is Associated With Coronary Microvascular Dysfunction in Patients With STEMI-A
Roberto Scarsini1, Denis Leonardi1, Andrea Bottardi1
1Department of Medicine, Division of Cardiology, University of Verona, Verona, Italy.
Background:
Up to 50% of patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI) develop coronary microvascular dysfunction (CMD).
Aims:
This study aims to assess whether a prothrombotic state of coronary blood, defined by thromboelastography (TEG), is associated with post-pPCI CMD in STEMI.
Methods:
TEG analysis of infarct-related coronary artery (IRA) blood was performed in 25 consecutive STEMI patients before and after successful pPCI. CMD was defined by high values of the angiography-derived index of microcirculatory resistance (IMRangio ≥ 40 units).
Results:
The median age was 59 (IQR 51-71) years. CMD was observed in 13 (52%) patients. Pre-pPCI Reaction (R) and Kinetic (K) time of the coronary blood from the IRA were inversely correlated with IMRangio (rho -0.45, p = 0.02; rho -0.62, p = 0.002 respectively). R time was significantly shorter in patients who developed CMD (10.7 [IQR 8.8, 13.1] vs. 18.2 [IQR 12.6, 24.2], p = 0.05), and it provided an overall good diagnostic accuracy in predicting CMD (AUC 0.75, [95% CI 0.53-0.96] p = 0.05). Similar relationship was founded for K time: 3.5 [IQR 2.2-4.6] versus 10.6 [IQR 4.5-30.0] min, p = 0.01; AUC 0.82, [95% CI 0.64-0.99] p = 0.01. Moreover, α angle was significantly larger (57.4 [IQR 46.5-64.8] vs. 40.0 [IQR 39.0-49.5], p = 0.03) in patients with CMD (AUC 0.78, [95% CI 0.57-0.98], p = 0.03). Coronary post-pPCI TEG parameters were not associated with CMD.
Conclusions:
In this proof-of-concept study, a prothrombotic state of coronary blood from the IRA is associated with CMD. Further studies are warranted to evaluate if TEG may enhance individualized therapies in patients with STEMI at risk of CMD.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Coronary Artery Disease III: Clinical Manifestations

